Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


Copyright Notice

Pfizer SWOT

Pfizer—a ***** Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one ***** the world's most profitable companies. It has a well-respected name known all over the world and commands some of ***** top *****, advertising, financial, and marketing talent. It produces two of the most well-known *****-brand drugs, Viagra and Lipitor in America today. Even ***** American Heart Association recommends the use of ***** such as Lipitor to reduce cholesterol when diet ***** exercise fail to reduce this common health problem. High ***** as a common health problem is only likely ***** increase with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied to Lipitor" which is dangerous for the company in the future as Lipitor's patent will expire ***** several years, ***** means it ***** face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has ***** been tainted by its association with Celebrex, a p*****in medication that has been tied to increased risk of heart *****s, in comparison to over-the-counter painkillers. The prominence of the Pfizer advertising campaign for this drug, followed by its rapid fall from grace undoubtedly damaged the company's trusted name.

Pfizer also manufactures Zol*****t, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing increased suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants and 'lifestyle' drugs like Viagra have come ***** ********** media scrutiny ***** ********** as examples of the over-prescription of ***** in ***** American *****care system in general. Healthcare in America is growing more and more expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay for drugs.

Now, Exubera, "the first and so far ***** commercially available inhaled-insulin diabetes treatment," is on ***** verge ***** turning in***** an "expensive failure" as Pfizer "***** been dogged by questi*****s about ***** safety, cost *****d convenience" (Berenson, 2007).

*****

According to the Pfizer press release section of its website, discomfort associated with fibromyaglia, a common chronic pain condition, has ***** shown ***** be significantly reduced ***** a new drug developed by Pfizer called Lyrica, "according to study results presented today at the ***** Academy ***** Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has ***** developed a new AIDS drug called Maraviroc, which is likely to considerably improve and extend the life of AIDS p*****ients who take the *****, ***** to researchers at the University of Pittsburg and Columbia University (Altman & Pollock, *****).

Threats

Both Merck and Schering-Plough, two of Pfizer's greatest rivals, plan to combine forces and develop a medicine ***** rival Lipitor. "The planned drug, meant to reduce levels of ***** harmful type of cholesterol in two ways, could hit the market when ***** patent expires in a few years" ("Merck and Schering-Plough Plan Ano*****r Cholesterol Drug,"

. . . . [END OF DISSERTATION PREVIEW]

Download complete paper (and others like it)    |    Order a one-of-a-kind, custom-written paper

© 2001–2016   |   Thesis Papers about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Term Papers Writing